The bioactivity of KR was confirmed in Ins2Akita mice when administered long-term (from 4- to 8-months of diabetes), since KR but not vehicle control increased TFAM+ mitochondrial nucleoids in the diabetic retina (arrowheads, Supplementary Fig. 9). Here, TFAM is linked to diabetes mellitus.